Open access
Aug 2026
Endothelial PLK2 as a metabolic rheostat and therapeutic target for pathological retinal and choroidal neovascularization
By maintaining mitochondrial bioenergetic efficiency and mitigating oxidative stress, PLK2 sustains the high-energy demands of pathological endothelial cell activation and sprouting and represents a promising therapeutic strategy for pathological ocular angiogenesis.
Ping-ping Fu, Wen Bai, Ying-Shun Pan et al.
· Cell Death Discovery · 0 citations